Osteoporosis is a chronic condition characterized by weakened bones, increasing the risk of fractures and other complications. As the population ages, the prevalence of osteoporosis is expected to rise, making
This month in endocrinology saw great strides in our understanding of semaglutide, the active ingredient in the Type-2 diabetes treatment drug Ozempic. A recent study by Novo Nordisk, makers of
PRINE Health is a unique multispecialty group centered around the chronic kidney disease patient population.
